synapsin 1 Search Results


90
Sino Biological anti human α syn immunomagnetic beads kit
Anti Human α Syn Immunomagnetic Beads Kit, supplied by Sino Biological, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/synapsin+1/Anti-Synapsin+I+%2F+Synapsin-1+Magnetic+Beads+Immunoprecipitation+(IP)+Kit/pm32538547-91-15-20
Average 90 stars, based on 1 article reviews
anti human α syn immunomagnetic beads kit - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

93
Cell Signaling Technology Inc anti phospho synapsin 1
Anti Phospho Synapsin 1, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/synapsin+1/Phospho-Synapsin-1+(Ser605)+Rabbit+mAb/pm39119847-339-12-13
Average 93 stars, based on 1 article reviews
anti phospho synapsin 1 - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier

96
Cell Signaling Technology Inc rabbit antisynapsin 1
Rabbit Antisynapsin 1, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/synapsin+1/Synapsin-1+XP+Rabbit+mAb/10__1186_slash_s43074___025___00165___8-225-8-11
Average 96 stars, based on 1 article reviews
rabbit antisynapsin 1 - by Bioz Stars, 2026-09
96/100 stars
  Buy from Supplier

95
Proteintech syn1
Syn1, supplied by Proteintech, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/synapsin+1/SYN1-Specific+Antibody/pm41616945-105-54-56
Average 95 stars, based on 1 article reviews
syn1 - by Bioz Stars, 2026-09
95/100 stars
  Buy from Supplier

92
Cell Signaling Technology Inc cd45
Phenotypic expression of the biomarkers. Immunostaining of the encapsulated hLSMCs under transit for 3 days: Alginate encapsulated hLSMCs of both groups, stored/under transit for 3 days have shown the expression of Pax6 + , stem-cell biomarkers (ABCG2 + , p63-α + ) and the mesenchymal biomarkers (VIM + , CD90 + , CD105 + and <t>CD45</t> − ) with respect to the control cells. Blue: DAPI, nuclear stain. Scale: 100 µM.
Cd45, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/synapsin+1/Synapsin-1+XP+Rabbit+mAb/pmc06861256-105-48-51
Average 92 stars, based on 1 article reviews
cd45 - by Bioz Stars, 2026-09
92/100 stars
  Buy from Supplier

90
Boster Bio anti syn1
Phenotypic expression of the biomarkers. Immunostaining of the encapsulated hLSMCs under transit for 3 days: Alginate encapsulated hLSMCs of both groups, stored/under transit for 3 days have shown the expression of Pax6 + , stem-cell biomarkers (ABCG2 + , p63-α + ) and the mesenchymal biomarkers (VIM + , CD90 + , CD105 + and <t>CD45</t> − ) with respect to the control cells. Blue: DAPI, nuclear stain. Scale: 100 µM.
Anti Syn1, supplied by Boster Bio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/synapsin+1/Anti-Synapsin+I%2FSYN1+Antibody+Picoband/pm41566018-150-48-50
Average 90 stars, based on 1 article reviews
anti syn1 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

92
Cell Signaling Technology Inc synapsin 1
Phenotypic expression of the biomarkers. Immunostaining of the encapsulated hLSMCs under transit for 3 days: Alginate encapsulated hLSMCs of both groups, stored/under transit for 3 days have shown the expression of Pax6 + , stem-cell biomarkers (ABCG2 + , p63-α + ) and the mesenchymal biomarkers (VIM + , CD90 + , CD105 + and <t>CD45</t> − ) with respect to the control cells. Blue: DAPI, nuclear stain. Scale: 100 µM.
Synapsin 1, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/synapsin+1/Synapsin-1+XP+Rabbit+mAb/pmc10909331-73-32-35
Average 92 stars, based on 1 article reviews
synapsin 1 - by Bioz Stars, 2026-09
92/100 stars
  Buy from Supplier

93
Cell Signaling Technology Inc synapsin 1 xp
Phenotypic expression of the biomarkers. Immunostaining of the encapsulated hLSMCs under transit for 3 days: Alginate encapsulated hLSMCs of both groups, stored/under transit for 3 days have shown the expression of Pax6 + , stem-cell biomarkers (ABCG2 + , p63-α + ) and the mesenchymal biomarkers (VIM + , CD90 + , CD105 + and <t>CD45</t> − ) with respect to the control cells. Blue: DAPI, nuclear stain. Scale: 100 µM.
Synapsin 1 Xp, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/synapsin+1/Synapsin-1+XP+Rabbit+mAb/pmc04614347-141-110-113
Average 93 stars, based on 1 article reviews
synapsin 1 xp - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier

90
MedChemExpress a syn1 100 pffs
Figure 2. C-terminal of a-syn plays a major role in the binding with vRAGE (A) Overlay of the 2D 1H-15N HSQC spectra of a-syn monomer alone (black) and that titrated by vRAGE (blue) at a molar ratio of 1:2 (a-syn:vRAGE). The cross- peaks of the negatively charged residues with significant CSDs (CSDs > 0.01 ppm) at the C terminus of a-syn are highlighted with black boxes and zoomed in on the top right. Experiments were performed two independent times. (B) Residue-specific CSDs of a-syn monomer titrated by vRAGE from (A). The domain organization of a-syn is shown on the top. The primary sequence of a-syn C terminus (residues 101–140) is shown, and the acidic residues are colored in red. The residues with CSDs >0.01 ppm are highlighted in blue. (C) NS-TEM <t>image</t> <t>of</t> <t>a-syn1-100</t> fibrils. Scale bar, 100 nm. Experiments were performed three independent times. (D) The binding kinetics of vRAGE with a-syn1-100 monomer (left) and a-syn1-100 PFF (right) determined by BLI assay. Experiments were performed in triplicate. Data are processed with GraphPad Prism 7. N.D., not detected.
A Syn1 100 Pffs, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/synapsin+1/Synapsin+I+Antibody/pm36130498-232-55-61
Average 90 stars, based on 1 article reviews
a syn1 100 pffs - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Alomone Labs antibodies against synaptic markers syn 1
Figure 2. C-terminal of a-syn plays a major role in the binding with vRAGE (A) Overlay of the 2D 1H-15N HSQC spectra of a-syn monomer alone (black) and that titrated by vRAGE (blue) at a molar ratio of 1:2 (a-syn:vRAGE). The cross- peaks of the negatively charged residues with significant CSDs (CSDs > 0.01 ppm) at the C terminus of a-syn are highlighted with black boxes and zoomed in on the top right. Experiments were performed two independent times. (B) Residue-specific CSDs of a-syn monomer titrated by vRAGE from (A). The domain organization of a-syn is shown on the top. The primary sequence of a-syn C terminus (residues 101–140) is shown, and the acidic residues are colored in red. The residues with CSDs >0.01 ppm are highlighted in blue. (C) NS-TEM <t>image</t> <t>of</t> <t>a-syn1-100</t> fibrils. Scale bar, 100 nm. Experiments were performed three independent times. (D) The binding kinetics of vRAGE with a-syn1-100 monomer (left) and a-syn1-100 PFF (right) determined by BLI assay. Experiments were performed in triplicate. Data are processed with GraphPad Prism 7. N.D., not detected.
Antibodies Against Synaptic Markers Syn 1, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/synapsin+1/Anti-Synapsin+I+(SYN1)+Antibody/pm34224822-150-30-36
Average 90 stars, based on 1 article reviews
antibodies against synaptic markers syn 1 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

93
Boster Bio syn1
Figure 2. DM mice exhibit synaptic deficits and increased neuroinflammation in the HIP. (A) Repre- sentative WB images showing the expression levels of the presynaptic protein synapsin I <t>(SYN1)</t> and the postsynaptic protein postsynaptic density protein 95 (PSD95) in the HIP of CTL and DM mice. β-actin was used as an internal control. (B) Semi-quantitative analysis of PSD95 and <t>SYN1</t> expression levels from immunoblot experiments. n = 6. (C) Representative images of Iba1 immunostaining in the HIP of CTL and DM mice. The area within the dashed box is magnified and displayed in the insets. Scale bars: 100 µm (main images) and 20 µm (insets). (D) Quantitative analysis of Iba1-positive microglia in the HIP of CTL and DM mice. n = 5. (E) qPCR analysis of iNOS and Arg1 mRNA levels in the HIP of CTL and DM mice. n = 6. (F) qPCR analysis of IL-6, IL-1β, and TNF-α mRNA levels in the HIP of CTL and DM mice. n = 6. (G) ELISA measuring IL-6, IL-1β, and TNF-α levels in the serum of CTL and DM mice. n = 3. Data are presented as mean ± SEM. Statistical significance was determined using a one-tailed unpaired t-test. * p < 0.05, ** p < 0.01, *** p < 0.001.
Syn1, supplied by Boster Bio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/synapsin+1/Anti-Phospho-Synapsin+I+(S9)+Rabbit+Monoclonal+Antibody/10__3390_slash_ijms26073355-363-18-32
Average 93 stars, based on 1 article reviews
syn1 - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier

Image Search Results


Phenotypic expression of the biomarkers. Immunostaining of the encapsulated hLSMCs under transit for 3 days: Alginate encapsulated hLSMCs of both groups, stored/under transit for 3 days have shown the expression of Pax6 + , stem-cell biomarkers (ABCG2 + , p63-α + ) and the mesenchymal biomarkers (VIM + , CD90 + , CD105 + and CD45 − ) with respect to the control cells. Blue: DAPI, nuclear stain. Scale: 100 µM.

Journal: Scientific Reports

Article Title: Encapsulation of human limbus-derived stromal/mesenchymal stem cells for biological preservation and transportation in extreme Indian conditions for clinical use

doi: 10.1038/s41598-019-53315-x

Figure Lengend Snippet: Phenotypic expression of the biomarkers. Immunostaining of the encapsulated hLSMCs under transit for 3 days: Alginate encapsulated hLSMCs of both groups, stored/under transit for 3 days have shown the expression of Pax6 + , stem-cell biomarkers (ABCG2 + , p63-α + ) and the mesenchymal biomarkers (VIM + , CD90 + , CD105 + and CD45 − ) with respect to the control cells. Blue: DAPI, nuclear stain. Scale: 100 µM.

Article Snippet: The antibody panel was composed of (a) ABCG2 (1:100, 18841, Santa Cruz Biotechnology, USA), Pax6 (1:300, 901301, BioLegend, USA), p63-α (1:100, 4892S, Cell Signalling technology, USA) and Col-III (1:100, ab7778, Abcam, UK), as positive markers of the human limbal stem cell phenotype; HLA-DR (1:100, ab55152, Abcam, UK), and CD45 (1:100, 13197, Cell Signalling Technology, USA) as negative marker for mesenchymal origin, (b) CD73 (1:100, 13160, Cell Signalling Technology, USA), CD105 (1:100, 376381, Santa Cruz Biotechnology, USA), and VIM (1:100, 6260, Santa Cruz Biotechnology, USA) as positive markers of the mesenchymal phenotype.

Techniques: Expressing, Immunostaining, Control, Staining

Quantification of the gene expression using real-time PCR. Immunostaining of the encapsulated hLSMCs under transit for 5 days: Alginate encapsulated hLSMCs stored at 4 °C did not show expression of the stem-cell (ABCG2 − ). The RT group cells have showed similar phenotype as the control group (ABCG2 + , Pax6 + p63-α + , VIM + , CD90 + , CD105 + , CD45 − , HLADR + , Col-III + , and CD73 + ). Blue: DAPI, nuclear stain. Scale : 100 µM.

Journal: Scientific Reports

Article Title: Encapsulation of human limbus-derived stromal/mesenchymal stem cells for biological preservation and transportation in extreme Indian conditions for clinical use

doi: 10.1038/s41598-019-53315-x

Figure Lengend Snippet: Quantification of the gene expression using real-time PCR. Immunostaining of the encapsulated hLSMCs under transit for 5 days: Alginate encapsulated hLSMCs stored at 4 °C did not show expression of the stem-cell (ABCG2 − ). The RT group cells have showed similar phenotype as the control group (ABCG2 + , Pax6 + p63-α + , VIM + , CD90 + , CD105 + , CD45 − , HLADR + , Col-III + , and CD73 + ). Blue: DAPI, nuclear stain. Scale : 100 µM.

Article Snippet: The antibody panel was composed of (a) ABCG2 (1:100, 18841, Santa Cruz Biotechnology, USA), Pax6 (1:300, 901301, BioLegend, USA), p63-α (1:100, 4892S, Cell Signalling technology, USA) and Col-III (1:100, ab7778, Abcam, UK), as positive markers of the human limbal stem cell phenotype; HLA-DR (1:100, ab55152, Abcam, UK), and CD45 (1:100, 13197, Cell Signalling Technology, USA) as negative marker for mesenchymal origin, (b) CD73 (1:100, 13160, Cell Signalling Technology, USA), CD105 (1:100, 376381, Santa Cruz Biotechnology, USA), and VIM (1:100, 6260, Santa Cruz Biotechnology, USA) as positive markers of the mesenchymal phenotype.

Techniques: Gene Expression, Real-time Polymerase Chain Reaction, Immunostaining, Expressing, Control, Staining

Tabular format denoting the number of cells showing positive expression of the phenotypic biomarkers.

Journal: Scientific Reports

Article Title: Encapsulation of human limbus-derived stromal/mesenchymal stem cells for biological preservation and transportation in extreme Indian conditions for clinical use

doi: 10.1038/s41598-019-53315-x

Figure Lengend Snippet: Tabular format denoting the number of cells showing positive expression of the phenotypic biomarkers.

Article Snippet: The antibody panel was composed of (a) ABCG2 (1:100, 18841, Santa Cruz Biotechnology, USA), Pax6 (1:300, 901301, BioLegend, USA), p63-α (1:100, 4892S, Cell Signalling technology, USA) and Col-III (1:100, ab7778, Abcam, UK), as positive markers of the human limbal stem cell phenotype; HLA-DR (1:100, ab55152, Abcam, UK), and CD45 (1:100, 13197, Cell Signalling Technology, USA) as negative marker for mesenchymal origin, (b) CD73 (1:100, 13160, Cell Signalling Technology, USA), CD105 (1:100, 376381, Santa Cruz Biotechnology, USA), and VIM (1:100, 6260, Santa Cruz Biotechnology, USA) as positive markers of the mesenchymal phenotype.

Techniques: Expressing, Control, Biomarker Discovery

Figure 2. C-terminal of a-syn plays a major role in the binding with vRAGE (A) Overlay of the 2D 1H-15N HSQC spectra of a-syn monomer alone (black) and that titrated by vRAGE (blue) at a molar ratio of 1:2 (a-syn:vRAGE). The cross- peaks of the negatively charged residues with significant CSDs (CSDs > 0.01 ppm) at the C terminus of a-syn are highlighted with black boxes and zoomed in on the top right. Experiments were performed two independent times. (B) Residue-specific CSDs of a-syn monomer titrated by vRAGE from (A). The domain organization of a-syn is shown on the top. The primary sequence of a-syn C terminus (residues 101–140) is shown, and the acidic residues are colored in red. The residues with CSDs >0.01 ppm are highlighted in blue. (C) NS-TEM image of a-syn1-100 fibrils. Scale bar, 100 nm. Experiments were performed three independent times. (D) The binding kinetics of vRAGE with a-syn1-100 monomer (left) and a-syn1-100 PFF (right) determined by BLI assay. Experiments were performed in triplicate. Data are processed with GraphPad Prism 7. N.D., not detected.

Journal: Cell reports

Article Title: Interaction of RAGE with α-synuclein fibrils mediates inflammatory response of microglia.

doi: 10.1016/j.celrep.2022.111401

Figure Lengend Snippet: Figure 2. C-terminal of a-syn plays a major role in the binding with vRAGE (A) Overlay of the 2D 1H-15N HSQC spectra of a-syn monomer alone (black) and that titrated by vRAGE (blue) at a molar ratio of 1:2 (a-syn:vRAGE). The cross- peaks of the negatively charged residues with significant CSDs (CSDs > 0.01 ppm) at the C terminus of a-syn are highlighted with black boxes and zoomed in on the top right. Experiments were performed two independent times. (B) Residue-specific CSDs of a-syn monomer titrated by vRAGE from (A). The domain organization of a-syn is shown on the top. The primary sequence of a-syn C terminus (residues 101–140) is shown, and the acidic residues are colored in red. The residues with CSDs >0.01 ppm are highlighted in blue. (C) NS-TEM image of a-syn1-100 fibrils. Scale bar, 100 nm. Experiments were performed three independent times. (D) The binding kinetics of vRAGE with a-syn1-100 monomer (left) and a-syn1-100 PFF (right) determined by BLI assay. Experiments were performed in triplicate. Data are processed with GraphPad Prism 7. N.D., not detected.

Article Snippet: The plates were colorated with 1-StepTM NBT/BCIP Substrate Solution (ThermoFisher, 34042) at RT for 10 min. And cells were imaged with the Leica DFC365 FX fluorescence microscopy and analyzed with Image J. Quantitative polymerase chain reaction BV2 cells were plated and treated with PBS, LPS (100 ng/mL), a-syn monomer (5 mM), a-syn PFFs (5 mM), a-syn1-100 PFFs (5 mM) and FPS-ZM1 (MCE, 945714-67-0) for 7 h, respectively.

Techniques: Binding Assay, Residue, Sequencing

Figure 5. a-Syn PFFs increase the expression of cytokines dependent on RAGE (A) Statistical analysis of the mRNA fold change of TNF-a, IL-1b, and IL-6. BV2 cells were treated with PBS (gray), LPS (red), a-syn monomer (pink), a-syn WT PFFs (dark blue), and a-syn1-100 PFFs (light blue), respectively. (B) Statistical analysis of mRNA fold change of TNF-a, IL-1b, and IL-6 after BV2 cells treated with PBS (gray), a-syn WT PFFs (dark blue), and a-syn WT PFFs in the presence of FPS-ZM1 at molar ratios of 1:1 (light green) and 1:5 (dark green). (C) Statistical analysis of mRNA fold change of TNF-a, IL-1b, and IL-6 after primary microglia cells treated with a-syn monomer (pink), a-syn WT PFFs (dark blue), and a-syn WT PFFs in the presence of FPS-ZM1 at molar ratios of 1:1 (light green) and 1:5 (dark green). (D) Statistical analysis of mRNA fold change of TNF-a, IL-1b, and IL-6. WT (solid) and RAGE knockout (KO) (texture) primary microglia were treated with a-syn monomer (pink) and a-syn WT PFFs (dark blue), respectively. The data were analyzed with GraphPad Prism 7. Data are the means ± SD; all experiments were performed in duplicate and performed at least three times. One-way ANOVA followed by Tukey’s correction. ns, p > 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001. Statistical information is provided in STAR Methods. See also Figure S5.

Journal: Cell reports

Article Title: Interaction of RAGE with α-synuclein fibrils mediates inflammatory response of microglia.

doi: 10.1016/j.celrep.2022.111401

Figure Lengend Snippet: Figure 5. a-Syn PFFs increase the expression of cytokines dependent on RAGE (A) Statistical analysis of the mRNA fold change of TNF-a, IL-1b, and IL-6. BV2 cells were treated with PBS (gray), LPS (red), a-syn monomer (pink), a-syn WT PFFs (dark blue), and a-syn1-100 PFFs (light blue), respectively. (B) Statistical analysis of mRNA fold change of TNF-a, IL-1b, and IL-6 after BV2 cells treated with PBS (gray), a-syn WT PFFs (dark blue), and a-syn WT PFFs in the presence of FPS-ZM1 at molar ratios of 1:1 (light green) and 1:5 (dark green). (C) Statistical analysis of mRNA fold change of TNF-a, IL-1b, and IL-6 after primary microglia cells treated with a-syn monomer (pink), a-syn WT PFFs (dark blue), and a-syn WT PFFs in the presence of FPS-ZM1 at molar ratios of 1:1 (light green) and 1:5 (dark green). (D) Statistical analysis of mRNA fold change of TNF-a, IL-1b, and IL-6. WT (solid) and RAGE knockout (KO) (texture) primary microglia were treated with a-syn monomer (pink) and a-syn WT PFFs (dark blue), respectively. The data were analyzed with GraphPad Prism 7. Data are the means ± SD; all experiments were performed in duplicate and performed at least three times. One-way ANOVA followed by Tukey’s correction. ns, p > 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001. Statistical information is provided in STAR Methods. See also Figure S5.

Article Snippet: The plates were colorated with 1-StepTM NBT/BCIP Substrate Solution (ThermoFisher, 34042) at RT for 10 min. And cells were imaged with the Leica DFC365 FX fluorescence microscopy and analyzed with Image J. Quantitative polymerase chain reaction BV2 cells were plated and treated with PBS, LPS (100 ng/mL), a-syn monomer (5 mM), a-syn PFFs (5 mM), a-syn1-100 PFFs (5 mM) and FPS-ZM1 (MCE, 945714-67-0) for 7 h, respectively.

Techniques: Expressing, Knock-Out

Figure 2. DM mice exhibit synaptic deficits and increased neuroinflammation in the HIP. (A) Repre- sentative WB images showing the expression levels of the presynaptic protein synapsin I (SYN1) and the postsynaptic protein postsynaptic density protein 95 (PSD95) in the HIP of CTL and DM mice. β-actin was used as an internal control. (B) Semi-quantitative analysis of PSD95 and SYN1 expression levels from immunoblot experiments. n = 6. (C) Representative images of Iba1 immunostaining in the HIP of CTL and DM mice. The area within the dashed box is magnified and displayed in the insets. Scale bars: 100 µm (main images) and 20 µm (insets). (D) Quantitative analysis of Iba1-positive microglia in the HIP of CTL and DM mice. n = 5. (E) qPCR analysis of iNOS and Arg1 mRNA levels in the HIP of CTL and DM mice. n = 6. (F) qPCR analysis of IL-6, IL-1β, and TNF-α mRNA levels in the HIP of CTL and DM mice. n = 6. (G) ELISA measuring IL-6, IL-1β, and TNF-α levels in the serum of CTL and DM mice. n = 3. Data are presented as mean ± SEM. Statistical significance was determined using a one-tailed unpaired t-test. * p < 0.05, ** p < 0.01, *** p < 0.001.

Journal: International Journal of Molecular Sciences

Article Title: Mesenchymal Stem Cells Restore Endothelial Integrity and Alleviate Emotional Impairments in a Diabetic Mouse Model via Inhibition of MMP-9 Activity

doi: 10.3390/ijms26073355

Figure Lengend Snippet: Figure 2. DM mice exhibit synaptic deficits and increased neuroinflammation in the HIP. (A) Repre- sentative WB images showing the expression levels of the presynaptic protein synapsin I (SYN1) and the postsynaptic protein postsynaptic density protein 95 (PSD95) in the HIP of CTL and DM mice. β-actin was used as an internal control. (B) Semi-quantitative analysis of PSD95 and SYN1 expression levels from immunoblot experiments. n = 6. (C) Representative images of Iba1 immunostaining in the HIP of CTL and DM mice. The area within the dashed box is magnified and displayed in the insets. Scale bars: 100 µm (main images) and 20 µm (insets). (D) Quantitative analysis of Iba1-positive microglia in the HIP of CTL and DM mice. n = 5. (E) qPCR analysis of iNOS and Arg1 mRNA levels in the HIP of CTL and DM mice. n = 6. (F) qPCR analysis of IL-6, IL-1β, and TNF-α mRNA levels in the HIP of CTL and DM mice. n = 6. (G) ELISA measuring IL-6, IL-1β, and TNF-α levels in the serum of CTL and DM mice. n = 3. Data are presented as mean ± SEM. Statistical significance was determined using a one-tailed unpaired t-test. * p < 0.05, ** p < 0.01, *** p < 0.001.

Article Snippet: The membranes were blocked and incubated overnight with the following antibodies: PSD95 (SYSN, Toronto, ON, Canada, 124002, 1:1000); SYN1 (SYSN, 106011, 1:1000); Cldn5 (Invitrogen, 35-2500, 1:1000); Ocln (Invitrogen, 71-1500, 1:1000); and MMP9 (Boster, Shanghai, China; PB9669, 1:1000).

Techniques: Expressing, Control, Western Blot, Immunostaining, Enzyme-linked Immunosorbent Assay, One-tailed Test

Figure 6. MSC treatment attenuated DM-induced neuroinflammation and synaptic deficits. (A) Representative immunofluorescence images of Iba1 staining in the HIP of mice from the CTL, MSC, DM, and DM+MSC groups. The dashed box indicates the magnified region shown in the insets. Scale bars: 100 µm (main images) and 20 µm (insets). (B) Quantitative analysis of Iba1+ microglia in the HIP. n = 4. (C) qPCR analysis of iNOS and Arg1 mRNA levels in the HIP of mice from the CTL, MSC, DM, and DM+MSC groups. n = 9. (D) qPCR analysis of mRNA levels of IL-6, IL-1β, and TNF-α in the HIP of mice from the CTL, MSC, DM, and DM+MSC groups. n = 9. (E) ELISA results showing serum levels of IL-6, IL-1β, and TNF-α in CTL, MSC, DM, and DM+MSC mice. n = 4. (F) Representative WB images of PSD95 and SYN1 expression in the HIP. β-actin was used as a loading control. (G) Semi-quantitative analysis of PSD95 and SYN1 protein levels. n = 6. Data are presented as mean ± SEM. Two-way ANOVA followed by Tukey’s post hoc test. ** p < 0.01, *** p < 0.001.

Journal: International Journal of Molecular Sciences

Article Title: Mesenchymal Stem Cells Restore Endothelial Integrity and Alleviate Emotional Impairments in a Diabetic Mouse Model via Inhibition of MMP-9 Activity

doi: 10.3390/ijms26073355

Figure Lengend Snippet: Figure 6. MSC treatment attenuated DM-induced neuroinflammation and synaptic deficits. (A) Representative immunofluorescence images of Iba1 staining in the HIP of mice from the CTL, MSC, DM, and DM+MSC groups. The dashed box indicates the magnified region shown in the insets. Scale bars: 100 µm (main images) and 20 µm (insets). (B) Quantitative analysis of Iba1+ microglia in the HIP. n = 4. (C) qPCR analysis of iNOS and Arg1 mRNA levels in the HIP of mice from the CTL, MSC, DM, and DM+MSC groups. n = 9. (D) qPCR analysis of mRNA levels of IL-6, IL-1β, and TNF-α in the HIP of mice from the CTL, MSC, DM, and DM+MSC groups. n = 9. (E) ELISA results showing serum levels of IL-6, IL-1β, and TNF-α in CTL, MSC, DM, and DM+MSC mice. n = 4. (F) Representative WB images of PSD95 and SYN1 expression in the HIP. β-actin was used as a loading control. (G) Semi-quantitative analysis of PSD95 and SYN1 protein levels. n = 6. Data are presented as mean ± SEM. Two-way ANOVA followed by Tukey’s post hoc test. ** p < 0.01, *** p < 0.001.

Article Snippet: The membranes were blocked and incubated overnight with the following antibodies: PSD95 (SYSN, Toronto, ON, Canada, 124002, 1:1000); SYN1 (SYSN, 106011, 1:1000); Cldn5 (Invitrogen, 35-2500, 1:1000); Ocln (Invitrogen, 71-1500, 1:1000); and MMP9 (Boster, Shanghai, China; PB9669, 1:1000).

Techniques: Immunofluorescence, Staining, Enzyme-linked Immunosorbent Assay, Expressing, Control